Policy Paper

Promoting a Proactive Policy Agenda

Policy Paper

Policy Solutions

Certain actions must be taken at the policy level to ensure that the marketplace evolves at the pace of scientific advances and that patient needs and preferences are kept central.

Report

Medicines in Development for Autoimmune Diseases 2016 Report

Report

Medicines in Development for Autoimmune Diseases 2016 Report

From PhRMA

People Behind the Science

From PhRMA

People Behind the Science

Video

I’m Not Average – Matt

Video

I'm Not Average: Matt Survives Cancer Despite the Odds

Report

Prescription Medicines: Costs in Context

Report

Prescription Medicines: Costs in Context

The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the country’s leading biopharmaceutical researchers and biotechnology companies.

Latest From TheBlog

ICYMI: More than 60 PhRMA company scientists visit Capitol Hill

By Andrew Powaleny on September 30, 2016 at 09:00 AM

Eradication of measles highlights the promise of vaccines in development

By Hannah Mooney on September 29, 2016 at 03:31 PM

Celebrating hope for patients and families on World Heart Day 2016

By Hannah Mooney on September 29, 2016 at 09:27 AM

4 recommendations for ICER

By Lauren Neves on September 26, 2016 at 03:17 PM